Jeffrey J. Saucerman, PhD, of the University of Virginia’s Department of Biomedical Engineering, and his collaborators have developed a new approach to machine learning – a form of artificial intelligence – to identify drugs that help minimize harmful scarring after a heart attack or other injuries.